Stay updated with breaking news from Genalyte inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ The "Auto-Immune Diseases Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,. ....
/PRNewswire/ The "Global Lab-on-a-Chip Market 2021-2027" report has been added to ResearchAndMarkets.com s offering. The global lab-on-a-chip market is. ....
Share this article Share this article ResearchAndMarkets.com s offering. The Global Biochip Market is expected to grow at an impressive rate of around 15% during the forecast period. The Global Biochip Market is driven by the growing prevalence of various chronic and infectious disease especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in the demand for personalized medicine solutions or targeted therapies especially for treating diseases like cancer. This in turn is expected to positively influence the market growth over the next few years. Additionally, increasing R&D activities and supportive government policies further propel the market. Furthermore, ongoing technological innovations and new product launches by the major players operating in the market is expected to create lucrative opportunities for market growth through 2026. ....
Genalyte Announces Oversubscribed $50 Million Financing Round to Expand Testing Menu and Deploy Platform Diagnostic and Analytics Company Aims to Revolutionize Laboratory Testing and Analytics News provided by Share this article SAN DIEGO, Jan. 11, 2021 /PRNewswire/ Genalyte, a leading diagnostics and analytics company, announced today the closure of $50 million in financing. Genalyte s Maverick™ Diagnostic System (MDS) uses silicon chip based photonic ring resonance technology to perform multiple, simultaneous, rapid tests on a small volume of whole blood or serum in twenty minutes. We are energized by the very enthusiastic response from Investors for this latest round of funding, said CEO Ashraf Hanna. Genalyte is uniquely positioned to improve the laboratory diagnostic and analytic space. We ve demonstrated the strength of our technology in our EUA authorized SARS-CoV-2 Multi-Antigen Serology Panel, which is able to measure 26 different an ....
Global Auto-Immune Diseases Diagnostic Testing Device Pipeline Assessment 2020 - ResearchAndMarkets.com tullahomanews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tullahomanews.com Daily Mail and Mail on Sunday newspapers.